Roche Acquires Rights to Technology and Patent Applications from AbVitro to Support Next-Generation Sequencing Pipeline
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it made a technology acquisition from AbVitro Inc, a company focused…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it made a technology acquisition from AbVitro Inc, a company focused…
Roche today announced the launch of new metabolite-testing reagent sets to determine the concentration of iron and phosp…
Today Roche announced that the Canadian Health Authority has accepted the use of its PCR based mycoplasma detection test…
Roche (SIX: RO, ROG; OTCQX: RHHBY) and BioLamina, Stockholm, Sweden today announced the signing of a research and develo…
Today Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the use of its PCR based mycoplasma…
Co-cultivation can be used in a wide variety of applications, including cell signalling and toxicology testing. A key go…
Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer…
Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer…
In an effort to improve preclinical cardiotoxicity assays, reduce drug testing attrition rates, and ensure drug safety,…
In May 2011, The University of Iowa, Roy J. Carver Center for Genomics (CCG), entered into an agreement with Roche Nimbl…